3.3. Overexpression of Anti-Phospho-Serum and Glucocorticoid-Regulated Kinase (SGK1) Correlated with Low Sensitivity of Bortezomib and Ixazomib in Multiple Myeloma (MM) Cells. Here, SGK1 is linked to Miyoshi myopathy.